Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Cholecystitis acute
ADR ID BADD_A00902
ADR Hierarchy
09      Hepatobiliary disorders
09.03      Gallbladder disorders
09.03.01      Cholecystitis and cholelithiasis
09.03.01.003      Cholecystitis acute
Description Acute inflammation of the GALLBLADDER wall. It is characterized by the presence of ABDOMINAL PAIN; FEVER; and LEUKOCYTOSIS. Gallstone obstruction of the CYSTIC DUCT is present in approximately 90% of the cases. [MeSH]
MedDRA Code 10008614
MeSH ID D041881
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acute acalculous cholecystitis | Acute cholecystitis | Calculus of bile duct with acute cholecystitis | Calculus of bile duct with acute cholecystitis, with obstruction | Calculus of bile duct with acute cholecystitis, without mention of obstruction | Calculus of gallbladder with acute cholecystitis | Calculus of gallbladder with acute cholecystitis, with obstruction | Calculus of gallbladder with acute cholecystitis, without mention of obstruction | Cholecystitis acute | Cholecystitis acute NOS | Acute calculous cholecystitis | Acute on chronic cholecystitis | Cholecystitis, Acute | Acute Cholecystitis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01242Lamivudine0.001012%
BADD_D01253Lenalidomide0.003134%
BADD_D01254Lenvatinib0.001119%
BADD_D01285Levothyroxine0.000015%
BADD_D01298Liraglutide--
BADD_D01336Macitentan0.000301%
BADD_D01449Metronidazole0.000026%
BADD_D01527Naltrexone--
BADD_D01567Nilotinib0.000392%
BADD_D01602Olmesartan0.000472%
BADD_D01629Osimertinib0.000112%
BADD_D01668Pantoprazole0.000090%
BADD_D01687Pazopanib0.000168%
BADD_D01804Posaconazole0.009456%
BADD_D01822Prasugrel0.000384%
BADD_D01831Prednisolone0.000070%
BADD_D01909Ramipril0.000093%
BADD_D01922Regorafenib0.000168%
BADD_D01933Ribavirin0.040350%
BADD_D01948Riociguat0.000385%
BADD_D01954Rivaroxaban0.000443%
BADD_D01955Rivastigmine0.000542%
BADD_D02028Sirolimus0.000134%
BADD_D02029Sitagliptin0.000080%
BADD_D02053Sofosbuvir0.000423%
BADD_D02058Sorafenib0.000112%
BADD_D02093Sulfasalazine0.000455%
BADD_D02100Sunitinib0.000728%
BADD_D02105Tacrolimus0.000297%
BADD_D02107Tafamidis0.000538%
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages